The Symptoms of Bladder Cancer and Understanding Adstiladrin Treatment

Signs and Symptoms of Bladder Cancer

Bladder cancer symptoms often overlap with other conditions, which can make it harder to identify at first. If you or a loved one are experiencing any of the following list of signs, it is important to consult a healthcare provider:

1. **Blood in the urine (hematuria)
   **The most common symptom of bladder cancer is blood in the urine, which may appear pink, red, or brown. This blood may be visible or detected only through a urine test. It’s important to note that blood in the urine does not always mean cancer, but it is something that requires medical attention.
2. **Frequent urination
   **Many people with bladder cancer report feeling the need to urinate more often than usual, even when their bladder is not full. This can happen during the day or night and can disrupt normal activities.
3. Pain or burning during urinationBladder cancer may cause discomfort or a burning sensation while urinating, similar to symptoms of a urinary tract infection (UTI). This can persist even after treatment for infections.
4. Urgency to urinate, even when the bladder is not fullA constant feeling of urgency can occur, even without much urine in the bladder. This symptom may be overlooked, especially in seniors, as it can be mistaken for common age-related bladder issues.
5. Lower back or pelvic painPain in the lower back or around the pelvic area, particularly on one side of the body, may be a sign that bladder cancer has advanced and is affecting nearby tissues or organs.
6. **Swelling in the legs and feet
   **In some cases, advanced bladder cancer can cause swelling in the lower legs and feet, which may result from the cancer affecting lymph nodes or disrupting blood circulation.
7. Unexplained weight loss or fatigueWhile these symptoms are more general and can be related to many health issues, persistent fatigue or unexpected weight loss can sometimes be associated with advanced bladder cancer.

It’s important to keep in mind that not everyone with bladder cancer will have the same symptoms, and some may experience different signs or no symptoms at all. If any of these symptoms arise, early consultation with a healthcare provider is crucial for further evaluation.

Bladder Cancer May Be More Common Than You Think

Bladder cancer is often associated with aging, and its prevalence among seniors may be higher than many people realize. According to the American Cancer Society’s estimates for 2024, approximately 83,190 new cases of bladder cancer will be diagnosed in the United States (about 63,070 in men and 20,120 in women). It is also expected that there will be about 16,840 deaths due to bladder cancer (about 12,290 in men and 4,550 in women) this year.

Bladder cancer primarily affects older adults, with about 9 out of 10 people diagnosed being over the age of 55. The average age at diagnosis is 73. Additionally, men are significantly more likely to develop bladder cancer than women. Overall, the lifetime risk of developing bladder cancer is about 1 in 28 for men and 1 in 89 for women.
Source: American Cancer Society

Adstiladrin Treatment for Bladder Cancer

Adstiladrin (nadofaragene firadenovec-vncg) is an FDA-approved gene therapy used to treat certain types of non-muscle invasive bladder cancer (NMIBC) that are unresponsive to Bacillus Calmette-Guérin (BCG) therapy. Adstiladrin works by delivering a gene that encodes for interferon alfa-2b directly into the bladder through a viral vector. This process enhances the body’s immune response, helping to fight cancer cells while reducing tumor recurrence and progression (Source: Adstiladrin).

Adstiladrin offers an innovative approach to NMIBC, utilizing gene therapy to stimulate the immune system and combat cancer cells. Clinical trials have shown that 51% of patients achieved a complete response within three months of treatment, offering hope for those with limited options after failing BCG therapy. The treatment is delivered directly into the bladder via catheter once every three months, providing a manageable schedule for patients (Source: Adstiladrin).

As with any advanced therapy, Adstiladrin may not be suitable for all patients and can cause side effects such as fatigue, urinary discomfort, and fever. Rare but serious risks, such as immune-related complications, may also occur, requiring close monitoring by healthcare providers. Patients with compromised immune systems may not be candidates for this treatment (Source: Adstiladrin).

Overall, Adstiladrin represents a significant advancement in the treatment of NMIBC, particularly for patients who have not responded to standard therapies. By combining gene therapy with immune modulation, it provides a novel option to reduce tumor recurrence and improve outcomes. Patients should consult with their healthcare provider to determine if Adstiladrin is the right treatment option for their condition (Source: Adstiladrin).

---

DailyAffairsNow is for informational purposes only. It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on DailyAffairsNow.